The GPC3 gene helps control growth signals, especially before birth, so tissues and organs develop in a more balanced way. When this gene does not work properly, growth can be less controlled, which may lead to Simpson-Golabi-Behmel syndrome, often with larger size at birth, distinctive facial features, and changes in organs or bones. In medicine, this gene is important because the GPC3 protein is often found at high levels in some liver cancers, which can help doctors identify certain tumors.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Others mainly help control when certain processes take place, where they happen, and how strongly they run. As a group, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, and medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
GPC3Gene function
What if the gene works
The GPC3 gene helps control how cells grow and respond to signals, especially before birth. Its protein sits on the cell surface and supports normal body shaping and organ development.
Risk
What if the gene does not work
Variants that reduce function of the GPC3 gene can cause Simpson-Golabi-Behmel syndrome, often with overgrowth, distinctive facial features, and birth differences. Milder and more severe variants can influence which features appear and how strongly.
Treatment
What does that mean for your treatment
For a pathogenic variant in the GPC3 gene, no treatment or drug choice specific to GPC3 is currently established in clinical guidelines; care is guided by the person’s symptoms and usual clinical monitoring. Separately, GPC3 is being studied as a cancer marker and drug target, especially in liver cancer, with targeted antibodies and engineered immune cell treatments under investigation.
Conditions associated with GPC3
Gene function
What if the gene works
During early growth, cells use the GPC3 gene to help manage signals that tell tissues when and where to grow. Its protein sits on the outer surface of cells, where it can catch and shape messages from nearby cells. Understanding how the GPC3 gene helps control growth signals makes it easier to see how organs and body structures form in an organized way.
GPC3 helps cells fine tune growth messages at their surface. It binds nearby signaling molecules, including Wnt and Hedgehog, two systems that guide growth and body patterning.
The protein from the GPC3 gene sits on the outside of the cell membrane. From that position, it helps present key signals to the cell and keeps communication local.
This gene is especially important during development before birth. It supports the orderly formation of tissues and organs by helping growth signals act in the right place at the right time.
By shaping how signals reach the cell, GPC3 helps pace cell growth and division. This supports balanced tissue building as the body develops.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help explain normal variation among people, including differences in appearance, metabolism, or the body’s response to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to a genetic condition or cause it.
Genetic variants
What if the gene does not work
Many variants in the GPC3 gene change glypican-3 so less of the protein reaches the cell surface, or it cannot bind and organize growth signals normally. These GPC3 gene variant effects on protein function range from milder changes that leave some activity to more severe variants that stop protein production or cell-surface attachment altogether. In Simpson-Golabi-Behmel syndrome, variants with a bigger functional impact are often linked to earlier or more noticeable features.
How variants are linked to conditions
Pathogenic variants in the GPC3 gene cause Simpson-Golabi-Behmel syndrome type 1, so GPC3 gene changes are a well-established cause of this X-linked overgrowth condition. People with this diagnosis may have larger than expected growth before and after birth, distinctive facial features, and differences affecting organs or the skeleton. Some also have a higher chance of certain childhood tumors, including Wilms tumor and hepatoblastoma.
A variant is not necessarily a diagnosis
Variants in genes are a normal part of human biology and are common throughout the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GPC3, risk is shaped mainly by whether a harmful gene change is inherited and whether the person is male or female, because this gene is on the X chromosome. Males with a disease-causing GPC3 change are much more likely to have clear features, while females may have milder signs or none at all. There is not enough evidence to say that lifestyle changes lower this genetic risk.
Inheritance of GPC3 variants
Inheritance of the GPC3 gene variants is usually X linked recessive. This means the GPC3 gene is on the X chromosome, so the pattern differs for sons and daughters. A mother carrying a GPC3 variant can pass it to either child, and sons who inherit the altered copy are more likely to be affected, while daughters are often carriers. A father with a GPC3 variant passes his X chromosome to all daughters and not to his sons.
What does my GPC3 result mean for my family?
For a disease-causing change in the GPC3 gene, family members on the mother’s side may also carry the same change. In families with this kind of result, boys are more likely to be affected, while girls may carry the change and sometimes have milder features. Close relatives, especially the mother, sisters, brothers, and maternal relatives, may want to talk with their care team about what this result could mean for them.
Genetic information
Genetic testing
How you find out about variants
To find out about changes in the GPC3 gene, GPC3 genetic testing uses a blood or saliva sample to read the gene and look for variants, including larger missing or extra pieces. Results can help confirm or clarify a diagnosis such as Simpson-Golabi-Behmel syndrome and may also help with family testing.
When should I consider getting a genetic test?
Testing for the GPC3 gene may be considered when a baby or child has unusual overgrowth, extra fingers or toes, heart or kidney differences, or other features that suggest Simpson-Golabi-Behmel syndrome. It can also help when this condition runs in the family or when a pregnancy shows similar findings on ultrasound.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and on the type of variant involved. Many factors, including age, environment, lifestyle, and medical history, also shape how the body works over time. In some cases, a genetic result may give a clear answer. For conditions influenced by many genes, however, genetic information provides context rather than certainty and is best understood alongside other parts of care. In areas like medication response, it can also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, or respond to drugs differently. These differences are common and are one reason medication response is not the same for everyone. In some cases, inherited gene changes can help explain why a person is more sensitive to a medicine or may need closer monitoring during treatment.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medicines. By looking at connections between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes can influence how strongly a drug works or how the body handles it. This information can support more informed and personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the GPC3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about medicines, side effects, or your general health are best discussed with your doctor or pharmacist.
History
GPC3 entered medical genetics through studies of families with a rare overgrowth condition now called Simpson-Golabi-Behmel syndrome. In the 1990s, researchers linked the condition to the GPC3 gene on the X chromosome, which helped clarify why the pattern could run through families in a sex linked way. Initially understood only through visible traits, later recognized as tied to a specific gene, this discovery marked an important step in connecting clinical features with a precise genetic cause. Later, GPC3 drew wider research interest when it was found to be strongly expressed in many liver cancers, especially hepatocellular carcinoma. From these first observations, research expanded steadily, and GPC3 became well known in both rare disease genetics and cancer pathology.